Holen Sie sich die Stockscreener-App
26.14
0.68%
-0.18
Handel nachbörslich:
26.14
Cg Oncology Inc Aktie (CGON) Neueste Nachrichten
CG Oncology Inc. Stock Analysis and ForecastHigh-profit trading signals - Autocar Professional
What drives CG Oncology Inc. stock priceConsistent high-yield stocks - Autocar Professional
Is CG Oncology Inc. a good long term investmentExplosive returns - jammulinksnews.com
Why CG Oncology Inc. stock attracts strong analyst attentionSteady Income Ideas - Newser
Why Did CG Oncology Plunge 10.78%? Insider Selling Sparks Concern - AInvest
What analysts say about CG Oncology Inc. stockConsistently high returns - PrintWeekIndia
Teacher Retirement System of Texas Cuts Position in CG Oncology, Inc. (NASDAQ:CGON) - Defense World
CG Oncology, Inc. (NASDAQ:CGON) Receives Consensus Rating of “Buy” from Brokerages - Defense World
Royal Bank Of Canada Issues Pessimistic Forecast for CG Oncology (NASDAQ:CGON) Stock Price - Defense World
September 19th Options Now Available For CG Oncology (CGON) - Nasdaq
Beyond The Numbers: 7 Analysts Discuss CG Oncology Stock - Benzinga
CG Oncology stock price target lowered to $53 at RBC Capital - Investing.com Canada
How CG Oncology Inc. stock performs during market volatilityFree Stock Selection - Newser
What makes CG Oncology Inc. stock price move sharplyFree Stock Movement Tracking - Newser
Morgan Stanley Lifts PT on CG Oncology (CGON) to $56, Keeps an Overweight Rating - MSN
CG Oncology Appoints Interim CFO After Resignation - The Globe and Mail
The Goldman Sachs Group Upgrades CG Oncology (NASDAQ:CGON) to “Strong-Buy” - Defense World
Precision Genetic Medicine Platform Could Disrupt Standard of Care in Metastatic Cancer, Other Indications of Unmet Needs - Finansavisen
CG Oncology's Strategic Pivot: How the Creto Pipeline is Redefining Value in Oncology Drug Development - AInvest
CG Oncology (NASDAQ:CGON) Upgraded to “Hold” at Wall Street Zen - Defense World
CG Oncology: Looking Undervalued Heading Toward FDA Submission (Upgrade) (NASDAQ:CGON) - Seeking Alpha
Cancer Rates Are Surging in Young Adults -- Here's Where the Smart Money Is Going - KamloopsBCNow
Cancer Rates Are Surging in Young Adults — Here’s Where the Smart Money Is Going - Cantech Letter
CG Oncology (NASDAQ:CGON) Price Target Raised to $56.00 at Morgan Stanley - Defense World
Rhumbline Advisers Buys 5,673 Shares of CG Oncology, Inc. (NASDAQ:CGON) - Defense World
CG Oncology (NASDAQ:CGON) Trading 4.7% Higher After Analyst Upgrade - Defense World
CGON: Morgan Stanley Raises Price Target for CG Oncology | CGON Stock News - GuruFocus
CG Oncology price target raised to $56 from $52 at Morgan Stanley - TipRanks
August 15th Options Now Available For CG Oncology (CGON) - Nasdaq
Non-Muscle Invasive Bladder Cancer Market Set to Grow Substantially Through 2034, DelveInsight Projects | CG Oncology, Pfizer, UroGen Pharma, Janssen Research & Development, LLC, Protara Therapeutics - The Globe and Mail
Cantor Fitzgerald Predicts CG Oncology FY2026 Earnings - Defense World
California State Teachers Retirement System Buys 20,763 Shares of CG Oncology, Inc. (NASDAQ:CGON) - Defense World
Squarepoint Ops LLC Makes New Investment in CG Oncology, Inc. (NASDAQ:CGON) - Defense World
CG Oncology to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference - Bluefield Daily Telegraph
CG Oncology Brings Breakthrough Bladder Cancer Treatment to Goldman Sachs Healthcare Conference - Stock Titan
Ameriprise Financial Inc. Grows Stock Holdings in CG Oncology, Inc. (NASDAQ:CGON) - Defense World
3.32%
1.57%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):